- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 266
Parkwalk debuts Cambridge Enterprise Fund VII
Parkwalk's seventh co-investment vehicle with University of Cambridge will nurture early-stage spinouts from the institution.
Feb 19, 2020Univercells absorbs KKR financing
KKR's Gamma Biosciences platform has committed $54.1m in financing to a new subsidiary of Univercells, whose existing investors include Takeda.
Feb 19, 2020FTQ confirms Theodorus investment
Fonds de solidarité FTQ has officially invested $5m in the fourth fund of ULB's Theodorus, with Théo Risopoulos named as the first team member of a new Quebec office.
Feb 19, 2020Daily deal net: February 18, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 18, 2020Concirrus burrows away $20m
Insurance underwriting software business Concirrus raised capital to fund product enhancements and entry into new verticals and geographies.
Feb 18, 2020DB Schenker shells out funding for Volocopter
DB Schenker, the logistics arm of Deutsche Bahn, has invested $21.7m in Volocopter, an air taxi developer already backed by corporates Daimler, Geely Holding and Intel.
Feb 18, 2020OMass compiles $53.9m series A
University of Oxford-founded OMass Therapeutics has extended its series A round to progress a pipeline targeting immunological and genetic disorders.
Feb 18, 2020OncoDNA hits the spot in series B round
Ackermans & van Haaren fund Sofinim returned for a $20.6m round that will fund the cancer-analysis software provider's expansion and product development.
Feb 18, 2020Carbon Clean Solutions captures $16m
CCSL will use the proceeds from the Marubeni and Chevron Technology Ventures-backed round to advance its carbon capture project pipeline.
Feb 18, 2020Karolinska Development celebrates financial results
Karolinska Development banked a $32.4m annual profit after the successful IPO of Aprea Therapeutics, amid improvements to its operational finances.
Feb 17, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


